| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $944.2M | $910.9M | $831.8M |
| YoY Revenue Growth % | +3.7% | +9.5% | — |
| Gross Profit | $455.0M | $435.4M | — |
| Gross Margin % | 48.2% | 47.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $243.6M | $244.3M | $189.7M |
| Operating Margin % | 25.8% | 26.8% | 22.8% |
| Net Income (GAAP) | $156.3M | $231.7M | $174.6M |
| EBITDA (Normalized) | $279.1M | $276.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $255.7M | $374.4M | $95.3M |
| Capital Expenditures (CapEx) | $44.4M | $40.2M | — |
| Free Cash Flow (FCF) | $211.3M | $334.1M | $95.3M |
| FCF Margin % | 22.4% | 36.7% | 11.5% |
| Return on Invested Capital (ROIC %) | 15.6% | 17.2% | — |
| Cash & Short-Term Equivalents | $295.0K | $807.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.24B | $1.12B | — |